Grab your lunch and join us at 12 PM ET for our Virtual Investor Lunch Break Series featuring Autonomix Medical . Register here: bit.ly/3UbZCkk $AMIX #Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals #DetectionTechnology #PancreaticCancerPain

#TuneInToday at 12 PM ET for our Virtual Investor Lunch Break Series featuring Autonomix Medical. Register here: bit.ly/3UbZCkk $AMIX #Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals #DetectionTechnology #PancreaticCancerPain

#HappeningTomorrow - Join us tomorrow at 12 PM ET for our Virtual Investor Lunch Break featuring Autonomix Medical. Register here: bit.ly/3UbZCkk $AMIX #Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals #DetectionTechnology #PancreaticCancerPain

ICYMI: Lori Bisson, CEO of Autonomix, presented at the Benzinga Virtual Healthcare Summit 2024. Watch the webcast replay: $AMIX #Electrophysiology #MedTech #PeripheralNervousSystem #NeuralSignals #DetectionTechnology #PancreaticCancerPain

Thank you MassDevice for highlighting the recently announced completion of the first three patient procedures for Autonomix's PoC human clinical trial evaluating the use of transvascular RF ablation for the treatment of #PancreaticCancerPain. bit.ly/3IJ8O9k $AMIX

Autonomix today announced the safe completion of the first three patient procedures for its proof-of-concept (PoC) human clinical trial evaluating the use of transvascular RF ablation for the treatment of #PancreaticCancerPain. For details: bit.ly/4aeMe4i $AMIX

#ICYMI - Our CEO, Lori Bisson, joined TraderTV.LIVE to discuss our PoC human clinical trial evaluating the use of transvascular RF ablation for the treatment of #PancreaticCancerPain. Watch here: bit.ly/3VaJHUp $AMIX #MedTech #Electrophysiology #PeripheralNervousSystem

Autonomix's PoC human clinical trial is the first trial to ever evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with #pancreaticcancer. Learn more: bit.ly/3TnR0GJ $AMIX #PancreaticCancerPain #MedTech

Our CEO, Lori Bisson, comments on the PoC human clinical trial and the potential for Autonomix's technology to address the significant unmet need for patients with pain associated with #pancreaticcancer. Read more: bit.ly/3TnR0GJ $AMIX #PancreaticCancerPain #MedTech

Autonomix today announced it has commenced patient enrollment for its proof-of-concept (PoC) human clinical trial evaluating the use of transvascular RF ablation for the treatment of #PancreaticCancerPain. For details: bit.ly/3TnR0GJ $AMIX #MedTech

Autonomix CEO, Lori Bisson, will join TraderTV.LIVE today at 2:45pm ET to discuss our PoC human clinical trial evaluating the use of transvascular RF ablation for the treatment of #PancreaticCancerPain. Tune-in here: bit.ly/3V6FiBJ $AMIX #MedTech